Tagrisso was linked to higher cardiac risks in patients with EGFR-mutant NSCLC, including a four-fold rise in cardiac events ...

Lung cancer remains a leading cause of cancer death globally, with a significant rise in cases among non-smokers attributed ...

A new case report details a novel genetic mutation linked to drug resistance in a non-small cell lung cancer patient ...

MAIA Biotechnology, Inc. (NYSEAMERICAN: MAIA) disclosed information relating to its Phase 2 THIO-101 trial in advanced non-small cell lung cancer through a press release on February 4, 2025. According ...

MAIA Biotechnology Announces Positive Efficacy Updates for Phase 2 THIO-101 Trial in Advanced Non-Small Cell Lung Cancer ...

With 44,000 new diagnoses each year, non-small cell lung cancer is the second most frequent neoplasm in Italy after breast ...

A new study from Moffitt Cancer Center could help doctors predict how well patients with a specific type of lung cancer will respond to new therapies.

A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled “Acquired RUFY1-RET rearrangement as a ...

Collaboration focuses on launching an AI-powered biomarker prediction panel targeting actionable biomarkers to revolutionize lung cancer diagnostics and enable commercialization of a diagnostic panel.

Lung cancer is the deadliest form of cancer for humans, and increasingly, non-smokers are being diagnosed. Scientists suggest ...

Air pollution is the leading cause behind the rise in lung cancer cases among non-smokers, especially women and those living ...

Cases of lung cancer among those who never smoked is on the rise and air pollution could be contributing to the increase, ...